MedCity Update – June 2015
View this email in your browser


From Dr Eliot Forster, MedCity’s Executive Chair 

Announcements over the past month testify to the increasing strength and reputation of the life sciences base of London and the greater south east. First up came the news that the number of new life sciences jobs in London created by international investment in our sector tripled in 2014 – a reflection of the fact that the diverse expertise of this region adds up to a businesses attractive whole.

That has been complemented by the decision of several well-regarded US health/life sciences firms to list on the London Stock Exchange; again, their choices are fuelled by a recognition of the variety of unique strengths that we are increasingly known for internationally.

Finally, huge congratulations to Keregen, winner of OneStart Europe 2015. Since setting up in 2013, OneStart has helped over 40 life sciences start-ups (mostly based in London, Oxford and Cambridge) raise funding of up to £3m – a huge achievement and an invaluable contribution to the UK’s life sciences ecosystem.

New life sciences jobs triple in London 

A record number of leading international companies, including Takeda, Pfizer and Cipla, have invested in London over the past year, according to figures from London & Partners. Fourteen companies generated a total of £24.35m and created over 325 new jobs in 2014-15, compared to 101 new jobs created by eight companies in the previous year.
Read more

US firms look to London for life sciences listings

New listings announcements by US life sciences companies have highlighted London’s growing profile as a place to secure funding, with Boston’s PureTech and California’s Verseon looking to the London Stock Exchange to float. 
Read more

Angels in MedCity – June presentation event

The third presentation event for emerging life sciences companies to pitch to angel investors takes place on Thursday 11 June. Find out more about joining as a company or a potential investor here.
Read more about Angels in MedCity

See more about London Business Angels

£100k for OneStart winner tackling neurodegeneration in Parkinson’s

London-based Keregen has won OneStart Europe 2015 to develop a business based on molecular technology with the potential to slow or event halt Parkinson’s Disease. Keregen’s science was originally developed at University College London.
Read more

Biotech investment in London and beyond

MedCity, Sidley Austin LLP and King’s College London host a half-day conference on Tuesday 9 June to explore the opportunities and challenges of investing in biotech in the UK and Europe.
Find out more

Londoneast-uk launches new start-up science space 

New research and manufacturing facilities for science and technology SMEs has been officially launched on the site of the former manufacturing site of Sanofi in Dagenham. Londoneast-uk offers 17 acres of specialist buildings and development plots, including laboratories, clean rooms and sterile manufacturing buildings. 

Read more

New Executive Dean for Life Sciences and Medicine at KCL

Professor Richard Trembath has been appointed Executive Dean of the Faculty of Life Sciences and medicine at King’s College London. He moves to lead KCL’s largest faculty from Queen Mary University of London, where he is currently Vice-Principal for Health and Executive Dean of the Barts and The London School of Medicine and Dentistry.

Read more

Meet MedCity at BIO

MedCity is partnering with UKTI to lead the UK delegation to the BIO International Convention, the world’s largest bioscience event. This year’s conference takes place in Philadelphia – contact us for more information.

Find out more

Industrialists wanted for BBSRC panels

BBSRC and is looking for life sciences industrialists to engage with policymaking and grant review through membership of strategic advisory panels and peer review bodies.  

Find out more

BBSRC FLIP fellowships

Applications are open for the next round of fellowships under BBSRC’s Flexible Interchange Programme, which promotes the movement of people between different organisations, including academia and industry. The closing date for applications is 15 July.

Find out more

Coming up

SBRI London Briefing Seminar: Older People With Multiple Morbidities, 25 June, SBRI Healthcare

MassChallenge #digitalhealth evening reception, 30 June, Digital Catapult and MassChallenge
Digital Health Forum, 1 July, Digital Catapult 
UK CEO and Investor Forum, 8 July, UK BioIndustry Association
Medical Device Regulations Training, 21 October, South East Health Technologies Alliance

Email us to share your event

MedCity was established in April 2014 by the Mayor of London with the capital’s three Academic Health Science Centres – Imperial College Academic Health Centre, King’s Health Partners and UCLPartners.

2 Royal College Street
London NW1 0NH
T: 020 7691 3588

The next edition of MedCity Update will be sent in July 2015.



Copyright © 2015 MedCity. All rights reserved.